MSD’s Phase II Cadence trial of Winrevair achieves primary goal
Cadence is a placebo-controlled, randomised, double-blind trial assessing Winrevair’s safety and efficacy in CpcPH patients.
Analysis
View MoreCool heads, smart chains
Biopharma companies are harnessing AI and predictive analytics to transform temperature controlled logistics, with new entrants and innovations bringing advanced monitoring and- control solutions. Claire Read speaks to Jim Bacon,...
Sustainability vs suitability
Integrating sustainability compliance
Bio shocks
Seal the deal